These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 21062413)

  • 1. The human and canine TERT promoters function equivalently in human and canine cells.
    Arendt ML; Nasir L; Morgan IM
    Vet Comp Oncol; 2010 Dec; 8(4):310-6. PubMed ID: 21062413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The canine telomerase catalytic subunit (dogTERT): characterisation of the gene promoter and identification of proximal core sequences necessary for specific transcriptional activity in canine telomerase positive cell lines.
    Long S; Argyle DJ; Gault EA; Campbell S; Nasir L
    Gene; 2005 Sep; 358():111-20. PubMed ID: 16051448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954.
    Plumb JA; Bilsland A; Kakani R; Zhao J; Glasspool RM; Knox RJ; Evans TR; Keith WN
    Oncogene; 2001 Nov; 20(53):7797-803. PubMed ID: 11753658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between human telomerase reverse transcriptase transcriptional level and telomerase activity in three ovarian cancer cell lines].
    Song Y; Kong BH; Liu PS; Ma DX; Jiang S
    Ai Zheng; 2003 May; 22(5):486-91. PubMed ID: 12753708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
    Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
    Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
    Song Y; Shen K; He CX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study on selective killing effect of Hsv-tk/GCV driven by human telomerase catalytic subunit promoter on human lung cancer cell A549].
    Tang XJ; Wang YP; Zhou QH; Che GW; Chen XH; Zhu DX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Apr; 24(2):148-52. PubMed ID: 17407070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated HSV-TK gene therapy using the human telomerase promoter induced apoptosis of small cell lung cancer cell line.
    Song JS; Kim HP
    Oncol Rep; 2004 Aug; 12(2):443-7. PubMed ID: 15254714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An experimental study on targeting suicide gene therapy for lung cancer with HSV-TK driven by hTERT promoter].
    Wang YP; Tang XJ; Zhou QH; Che GW; Chen XH; Zhu DX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):701-5. PubMed ID: 19024294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter].
    Kong BH; Song Y; Ma DX; Qu X; Jiang S
    Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):390-5. PubMed ID: 15312323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of cell cycle- and differentiation stage-dependent human telomerase reverse transcriptase expression in single living cancer cells.
    Edqvist A; Rebetz J; Järås M; Rydelius A; Skagerberg G; Salford LG; Widegren B; Fan X
    Mol Ther; 2006 Jul; 14(1):139-48. PubMed ID: 16584924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of canine telomerase in vitro and in vivo using RNAi: further development of a natural canine model for telomerase-based cancer therapies.
    Lund JR; Paoloni M; Kurzman I; Padilla M; Argyle DJ
    Vet J; 2008 Aug; 177(2):192-7. PubMed ID: 17981480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
    Song Y; Shen K; Yu JR
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of human and mouse telomerase reverse transcriptase (TERT) promoter activity during testis development.
    Weise JM; Güneş C
    Mol Reprod Dev; 2009 Mar; 76(3):309-17. PubMed ID: 18729084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential transcriptional regulation of human telomerase in a cellular model representing important genetic alterations in esophageal squamous carcinogenesis.
    Quante M; Heeg S; von Werder A; Goessel G; Fulda C; Doebele M; Nakagawa H; Beijersbergen R; Blum HE; Opitz OG
    Carcinogenesis; 2005 Nov; 26(11):1879-89. PubMed ID: 15958520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters.
    Majumdar AS; Hughes DE; Lichtsteiner SP; Wang Z; Lebkowski JS; Vasserot AP
    Gene Ther; 2001 Apr; 8(7):568-78. PubMed ID: 11319624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-specific killing by the CD suicide gene using the human telomerase reverse transcriptase promoter.
    Liu J; Zou WG; Lang MF; Luo J; Sun LY; Wang XN; Qian QJ; Liu XY
    Int J Oncol; 2002 Sep; 21(3):661-6. PubMed ID: 12168115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-specific expression detected with the use of an expression vector driven by human telomerase reverse transcriptase gene promoter.
    Yin J; Fu P; Wang X; Jin G; Xiu R
    J Lab Clin Med; 2004 Dec; 144(6):302-6. PubMed ID: 15614252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity.
    Irving J; Wang Z; Powell S; O'Sullivan C; Mok M; Murphy B; Cardoza L; Lebkowski JS; Majumdar AS
    Cancer Gene Ther; 2004 Mar; 11(3):174-85. PubMed ID: 14726958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferentially enhanced gene expression from a synthetic human telomerase reverse transcriptase promoter in human cancer cells.
    Kim SJ; Lee HS; Shin JH; Kim CG; Jeong S; Park K; Choe H; Lee H
    Oncol Rep; 2006 Nov; 16(5):975-9. PubMed ID: 17016580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.